These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 18485547)

  • 21. Multiple alternating immunizations with DNA vaccine and replication incompetent adenovirus expressing gB of pseudorabies virus protect animals against lethal virus challenge.
    Kim SJ; Kim HK; Han YW; Aleyas AG; George JA; Yoon HA; Yoo DJ; Kim K; Eo SK
    J Microbiol Biotechnol; 2008 Jul; 18(7):1326-34. PubMed ID: 18667863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost.
    Xiao Y; Aldaz-Carroll L; Ortiz AM; Whitbeck JC; Alexander E; Lou H; Davis HL; Braciale TJ; Eisenberg RJ; Cohen GH; Isaacs SN
    Vaccine; 2007 Jan; 25(7):1214-24. PubMed ID: 17098336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine.
    Golden JW; Hooper JW
    Virology; 2008 Jul; 377(1):19-29. PubMed ID: 18482742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection of mice against the highly pathogenic VV
    Bissa M; Quaglino E; Zanotto C; Illiano E; Rolih V; Pacchioni S; Cavallo F; De Giuli Morghen C; Radaelli A
    Antiviral Res; 2016 Oct; 134():182-191. PubMed ID: 27637905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. L1R, A27L, A33R and B5R vaccinia virus genes expressed by fowlpox recombinants as putative novel orthopoxvirus vaccines.
    Pacchioni SM; Bissa M; Zanotto C; Morghen Cde G; Illiano E; Radaelli A
    J Transl Med; 2013 Apr; 11():95. PubMed ID: 23578094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of protective humoral immune responses against Herpes simplex virus-2 in DNA-immunized guinea-pigs using protein boosting.
    Fotouhi F; Soleimanjahi H; Roostaee MH; Behzadian F
    FEMS Immunol Med Microbiol; 2008 Oct; 54(1):18-26. PubMed ID: 18647350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice.
    Li Y; Ye J; Cao S; Xiao S; Zhao Q; Liu X; Jin M; Chen H
    J Gene Med; 2009 Jan; 11(1):57-65. PubMed ID: 19006097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
    Paran N; Suezer Y; Lustig S; Israely T; Schwantes A; Melamed S; Katz L; Preuss T; Hanschmann KM; Kalinke U; Erez N; Levin R; Velan B; Löwer J; Shafferman A; Sutter G
    J Infect Dis; 2009 Jan; 199(1):39-48. PubMed ID: 19012492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microarray assay for evaluation of the genetic stability of modified vaccinia virus Ankara B5R gene.
    Laassri M; Meseda CA; Williams O; Merchlinsky M; Weir JP; Chumakov K
    J Med Virol; 2007 Jun; 79(6):791-802. PubMed ID: 17457926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin.
    Bell E; Shamim M; Whitbeck JC; Sfyroera G; Lambris JD; Isaacs SN
    Virology; 2004 Aug; 325(2):425-31. PubMed ID: 15246280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII.
    Ramanathan MP; Kutzler MA; Kuo YC; Yan J; Liu H; Shah V; Bawa A; Selling B; Sardesai NY; Kim JJ; Weiner DB
    Vaccine; 2009 Jul; 27(32):4370-80. PubMed ID: 19497647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA priming and killed virus boosting vaccination strategy can augment the immune response to pseudorabies virus.
    Chen ZH; Guo X; Ge XN; Jia H; Yang HC
    Acta Virol; 2007; 51(3):163-70. PubMed ID: 18076306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of DNA priming-protein boosting on enhancing humoral immunity and protecting mice against lethal HSV infections.
    Soleimanjahi H; Roostaee MH; Rasaee MJ; Mahboudi F; Kazemnejad A; Bamdad T; Zandi K
    FEMS Immunol Med Microbiol; 2006 Feb; 46(1):100-6. PubMed ID: 16420602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A DNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protects mice against lethal challenge.
    De Paula SO; Lima DM; de Oliveira França RF; Gomes-Ruiz AC; da Fonseca BA
    Arch Virol; 2008; 153(12):2215-23. PubMed ID: 19002647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge.
    Hooper JW; Golden JW; Ferro AM; King AD
    Vaccine; 2007 Feb; 25(10):1814-23. PubMed ID: 17240007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates.
    Hooper JW; Ferro AM; Golden JW; Silvera P; Dudek J; Alterson K; Custer M; Rivers B; Morris J; Owens G; Smith JF; Kamrud KI
    Vaccine; 2009 Dec; 28(2):494-511. PubMed ID: 19833247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Japanese encephalitis virus DNA vaccine candidates in rhesus monkeys [Macaca mulatta].
    Bharati K; Rani R; Vrati S
    Vaccine; 2009 Jan; 27(1):10-6. PubMed ID: 18996161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune response induced by a different combined immunization of HBsAg vaccine.
    Wu T; Chen M; Ou SH; Cheng T; Zhang J; Xia NS
    Intervirology; 2007; 50(5):336-40. PubMed ID: 17700028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccine.
    Ferrier-Rembert A; Drillien R; Tournier JN; Garin D; Crance JM
    Vaccine; 2008 Mar; 26(14):1794-804. PubMed ID: 18336966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.